We are live on ! Find out more
INSP icon

Inspire Medical Systems

407 hedge funds and large institutions have $9.11B invested in Inspire Medical Systems in 2023 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 124 increasing their positions, 140 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 87 | Existing positions closed: 51

57% more funds holding in top 10

Funds holding in top 10: 711 (+4)

36% more capital invested

Capital invested by funds: $6.68B → $9.11B (+$2.43B)

9% more funds holding

Funds holding: 373407 (+34)

5% more call options, than puts

Call options by funds: $76.8M | Put options by funds: $73.3M

2.59% less ownership

Funds ownership: 98.88%96.29% (-2.6%)

11% less repeat investments, than reductions

Existing positions increased: 124 | Existing positions reduced: 140

Holders
407
Holders Change
+34
Holders Change %
+9.12%
% of All Funds
6.39%
Holding in Top 10
11
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+57.14%
% of All Funds
0.17%
New
87
Increased
124
Reduced
140
Closed
51
Calls
$76.8M
Puts
$73.3M
Net Calls
+$3.46M
Net Calls Change
-$587K
Name Holding Trade Value Shares
Change
Change in
Stake
ONGA
226
O'Neil Global Advisors
California
$1.04M +$410K +1,434 +82%
KOCAA
227
Knights of Columbus Asset Advisors
Connecticut
$1.03M
PP
228
PDT Partners
New York
$1.01M -$3.47M -12,130 -80%
Bessemer Group
229
Bessemer Group
New Jersey
$1M +$884K +3,095 New
LGA
230
Lebenthal Global Advisors
New York
$1,000K -$45.7K -160 -5%
NFG
231
Norris Financial Group
South Carolina
$996K +$877K +3,069 New
AR
232
Advisory Research
Illinois
$944K +$831K +2,907 New
CANY
233
Caxton Associates (New York)
New York
$908K +$799K +2,796 New
AIA
234
Affinity Investment Advisors
California
$901K -$362K -1,266 -31%
AG
235
AIA Group
Hong Kong
$873K +$768K +2,688 New
EAMA
236
EFG Asset Management (Americas)
Florida
$830K +$731K +2,557 New
ECI
237
EFG Capital International
Florida
$830K +$731K +2,557 New
OAM
238
Oppenheimer Asset Management
New York
$810K +$79.1K +277 +12%
Verition Fund Management
239
Verition Fund Management
Connecticut
$803K +$449K +1,572 +175%
Cetera Investment Advisers
240
Cetera Investment Advisers
Illinois
$800K +$704K +2,463 New
AWM
241
Avior Wealth Management
Nebraska
$776K +$72.3K +253 +12%
PFO
242
Pathstone Family Office
New Jersey
$771K -$1.14K -4 -0.2%
PFS
243
Prospera Financial Services
Texas
$755K -$8K -28 -1%
MSRPS
244
Maryland State Retirement & Pension System
Maryland
$738K +$649K +2,272 New
HighTower Advisors
245
HighTower Advisors
Illinois
$735K +$159K +558 +33%
IMRF
246
Illinois Municipal Retirement Fund
Illinois
$733K
LP
247
LMR Partners
United Kingdom
$727K +$639K +2,238 New
BC
248
Bridgefront Capital
Texas
$667K +$587K +2,056 New
Creative Planning
249
Creative Planning
Kansas
$655K +$167K +586 +41%
CAM
250
Cresset Asset Management
Illinois
$655K +$577K +2,019 New

INSP Hedge Fund Activity: Q2 2023 in Review

407 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q2 2023, worth a combined $9.11B — up 36% from $6.68B a quarter earlier.

Buyers outnumbered sellers: 87 funds opened new INSP positions and 51 closed out — a net gain of 36 holders — while 124 added to existing stakes and 140 trimmed.

The largest buyer was D.E. Shaw & Co, adding an estimated $57.7M. The largest seller was BlackRock, cutting an estimated $133M.

  • 407 institutional investors held Inspire Medical Systems (INSP) as of Q2 2023, up from 373 in Q1 2023.
  • Funds reported $9.11B of Inspire Medical Systems stock for Q2 2023, up 36% quarter-over-quarter.
  • 87 funds opened new Inspire Medical Systems positions in Q2 2023 and 51 closed out, a net change of +36 holders.
  • The largest Inspire Medical Systems buyer in Q2 2023 was D.E. Shaw & Co, an estimated $57.7M added.
  • The largest Inspire Medical Systems seller in Q2 2023 was BlackRock, an estimated $133M sold.

Based on aggregated 13F filings for Q2 2023.